Anti-angiogenic activity of curcumin in cancer therapy: a narrative review

Curcumin is a naturally occurring polyphenol isolated from Curcuma longa that has various pharmacological activities, including, anti-inflammatory, anti-oxidant and anti-cancer properties. The anticancer effect of curcumin is attributed to activation of apoptotic pathways in cancer cells, as well as...

Full description

Bibliographic Details
Main Authors: Shakeri, A., Ward, Natalie, Panahi, Y., Sahebkar, A.
Format: Journal Article
Published: 2018
Online Access:http://hdl.handle.net/20.500.11937/69444
_version_ 1848762043096629248
author Shakeri, A.
Ward, Natalie
Panahi, Y.
Sahebkar, A.
author_facet Shakeri, A.
Ward, Natalie
Panahi, Y.
Sahebkar, A.
author_sort Shakeri, A.
building Curtin Institutional Repository
collection Online Access
description Curcumin is a naturally occurring polyphenol isolated from Curcuma longa that has various pharmacological activities, including, anti-inflammatory, anti-oxidant and anti-cancer properties. The anticancer effect of curcumin is attributed to activation of apoptotic pathways in cancer cells, as well as inhibition of inflammation and angiogenesis in the tumour microenvironment and suppression of tumour metastasis. Angiogenesis, which is the formation of new blood vessels from pre-existing ones, is a fundamental step in tumour growth and expansion. Several reports have demonstrated that curcumin inhibits angiogenesis in a wide variety of tumour cells through the modulation of various cell signaling pathways which involve transcription factors, protein kinases, growth factors and enzymes. This review provides an updated summary of the various pathways and molecular targets that are regulated by curcumin to elicit its anti-angiogenic activity.
first_indexed 2025-11-14T10:41:17Z
format Journal Article
id curtin-20.500.11937-69444
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T10:41:17Z
publishDate 2018
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-694442019-03-05T03:52:17Z Anti-angiogenic activity of curcumin in cancer therapy: a narrative review Shakeri, A. Ward, Natalie Panahi, Y. Sahebkar, A. Curcumin is a naturally occurring polyphenol isolated from Curcuma longa that has various pharmacological activities, including, anti-inflammatory, anti-oxidant and anti-cancer properties. The anticancer effect of curcumin is attributed to activation of apoptotic pathways in cancer cells, as well as inhibition of inflammation and angiogenesis in the tumour microenvironment and suppression of tumour metastasis. Angiogenesis, which is the formation of new blood vessels from pre-existing ones, is a fundamental step in tumour growth and expansion. Several reports have demonstrated that curcumin inhibits angiogenesis in a wide variety of tumour cells through the modulation of various cell signaling pathways which involve transcription factors, protein kinases, growth factors and enzymes. This review provides an updated summary of the various pathways and molecular targets that are regulated by curcumin to elicit its anti-angiogenic activity. 2018 Journal Article http://hdl.handle.net/20.500.11937/69444 10.2174/1570161116666180209113014 restricted
spellingShingle Shakeri, A.
Ward, Natalie
Panahi, Y.
Sahebkar, A.
Anti-angiogenic activity of curcumin in cancer therapy: a narrative review
title Anti-angiogenic activity of curcumin in cancer therapy: a narrative review
title_full Anti-angiogenic activity of curcumin in cancer therapy: a narrative review
title_fullStr Anti-angiogenic activity of curcumin in cancer therapy: a narrative review
title_full_unstemmed Anti-angiogenic activity of curcumin in cancer therapy: a narrative review
title_short Anti-angiogenic activity of curcumin in cancer therapy: a narrative review
title_sort anti-angiogenic activity of curcumin in cancer therapy: a narrative review
url http://hdl.handle.net/20.500.11937/69444